Newsroom

Sorted by: Latest

-

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform

CHICAGO & ITASCA, Ill.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group’s StemFit™ stem cell culture products using Syntax Bio’s proprietary Cellgorithm™ platform. Through the collaboration, AHN is providing Syntax Bio with Ste...
-

Acxiom Recognized as Leader in Snowflake’s Modern Marketing Data Stack Report

CONWAY, Ark.--(BUSINESS WIRE)--Acxiom, the connected data and technology foundation for the world’s leading brands, today announced at Cannes Lions 2026 that it has been recognized by Snowflake, the AI Data Cloud company, as a “Leader” in Identity & Onboarding and “One to Watch” in Collaboration in Snowflake’s The Modern Marketing Data Stack 2026: Governing the Agentic Enterprise report. Acxiom was recognized in Snowflake’s report for identity and data solutions embedded in Snowflake’s AI D...
-

Iterable Recognized as Leader in Snowflake’s Modern Marketing Data Stack Report

CANNES, France--(BUSINESS WIRE)--Iterable announced at Cannes Lions that it has been recognized for the fourth consecutive year in Snowflake's Modern Marketing Data Stack report....
-

Amsterdam & Partners LLP Files UN Submission Challenging Detention of Fintech Executive

LONDON--(BUSINESS WIRE)--Amsterdam & Partners LLP today confirms that it has submitted a petition to the United Nations Working Group on Arbitrary Detention on behalf of Uktam Xasanov, CEO of fintech platform Solfy Uzbekistan, arguing that his arrest and continued detention violate both international law and Uzbekistan’s domestic legal obligations. Crucially, it is clear that the arrest and arbitrary detention of Mr. Xasanov was undertaken based entirely on a discriminatory assessment of hi...
-

Mount Sinai Health System Partners with Signal 1 to Strengthen AI Governance and Accelerate Value Realization

TORONTO--(BUSINESS WIRE)--Signal 1's AI Management to centralize oversight, governance and performance monitoring of Mt. Sinai's portfolio of artificial intelligence solutions...
-

Toy Story 5 Soars to Infinity and Beyond with All-Time Highest Total Revenue for a June Opening Weekend at Marcus Theatres

MILWAUKEE--(BUSINESS WIRE)--Marcus Theatres®, the nation’s fourth largest theatre circuit and a division of Marcus Corporation (NYSE: MCS), today announced that the opening weekend of Toy Story 5 and strong carryover performances from several films delivered record total revenue and record combined concession, merchandise, and food and beverage revenue for a June opening weekend. Fans of all ages turned out for Toy Story 5, from young children meeting Jessie, Woody and Buzz Lightyear for the fi...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...